APLM
Apollomics Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.05
+4.49%Margins
Gross margin
100.0%
EBITDA margin
-110.1%
EBIT margin
-111.4%
Net margin
-128.7%
FCF margin
-211.7%
343.1%
Return on equity
-162.9%
Return on assets
372.2%
Return on invested capital
0.95x
Asset turnover
-$18.0M
Cash from operations
$1.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025